chr8-127273163-GATAA-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NR_117099.1(CASC21):n.148+28384_148+28387delATAA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00391 in 152,146 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.0039 ( 1 hom., cov: 32)
Consequence
CASC21
NR_117099.1 intron
NR_117099.1 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.479
Genes affected
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASC21 | NR_117099.1 | n.148+28384_148+28387delATAA | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCAT1 | ENST00000644021.1 | n.148+28380_148+28383delATAA | intron_variant | |||||||
PCAT1 | ENST00000645463.1 | n.856-19648_856-19645delATAA | intron_variant | |||||||
PCAT1 | ENST00000646670.1 | n.1065-66117_1065-66114delATAA | intron_variant | |||||||
PCAT1 | ENST00000647190.2 | n.1192-19648_1192-19645delATAA | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00392 AC: 596AN: 152028Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
596
AN:
152028
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00391 AC: 595AN: 152146Hom.: 1 Cov.: 32 AF XY: 0.00398 AC XY: 296AN XY: 74372
GnomAD4 genome
AF:
AC:
595
AN:
152146
Hom.:
Cov.:
32
AF XY:
AC XY:
296
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3472
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Familial prostate cancer Other:1
association, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at